Literature DB >> 9683038

Increased erythrocyte aggregation in spontaneously hypertensive rats.

D Lominadze1, I G Joshua, D A Schuschke.   

Abstract

Alterations of red blood cell (RBC) aggregation and plasma viscosity are major contributors to the changes in blood rheologic properties that cause an increase in peripheral vascular resistance during the development of hypertension. Although basic research and clinical study have provided considerable understanding of the pathophysiology of hypertension, the objective of this study was to determine whether an increase in RBC aggregability and plasma viscosity precede or accompany the development of high arterial blood pressure. To address this question, RBC aggregation and plasma viscosity were studied in spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY) at 3 and 12 weeks of age. The plasma concentrations of fibrinogen and fibronectin (FN) were also analyzed in both age groups. RBC aggregability and plasma viscosity were increased in both young and mature SHR compared to age-matched normotensive WKY rats. Mean arterial blood pressure and diastolic pressures were increased in mature hypertensive rats, whereas in young SHR only diastolic pressure was elevated significantly. The concentration of fibrinogen was higher only in the mature hypertensive rats, whereas plasma FN content was greater in both 3- and 12-week-old SHR compared to age-matched WKY. These results show the existence of increased RBC aggregability and plasma hyperviscosity not only during the established phase of hypertension, but also during the early stage of hypertension development, when mean arterial blood pressure is not yet significantly elevated in the genetically hypertensive rat model. These changes may be related to significant increase in the plasma protein FN, which occurs at the same time as the RBC aggregability and plasma viscosity changes. These results may increase attention to changes in the rheologic properties and to the mechanisms involved in these processes in the early stages of hypertension development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683038     DOI: 10.1016/s0895-7061(98)00056-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  24 in total

1.  Involvement of fibrinogen specific binding in erythrocyte aggregation.

Authors:  David Lominadze; William L Dean
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

2.  Hyperfibrinogenemia-mediated astrocyte activation.

Authors:  Vincent D Clark; Ailey Layson; Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Brain Res       Date:  2018-08-25       Impact factor: 3.252

3.  Fibrinogen-induced increased pial venular permeability in mice.

Authors:  Nino Muradashvili; Natia Qipshidze; Charu Munjal; Srikanth Givvimani; Richard L Benton; Andrew M Roberts; Suresh C Tyagi; David Lominadze
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-12       Impact factor: 6.200

4.  Fibrinogen alters mouse brain endothelial cell layer integrity affecting vascular endothelial cadherin.

Authors:  Nino Muradashvili; Neetu Tyagi; Reeta Tyagi; Charu Munjal; David Lominadze
Journal:  Biochem Biophys Res Commun       Date:  2011-09-02       Impact factor: 3.575

5.  Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat.

Authors:  Angela Y Chen; Frank A DeLano; Shakti R Valdez; Jessica N Ha; Hainsworth Y Shin; Geert W Schmid-Schönbein
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

6.  Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.

Authors:  Nino Muradashvili; Richard L Benton; Kathryn E Saatman; Suresh C Tyagi; David Lominadze
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

7.  Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats.

Authors:  David Lominadze; Dale A Schuschke; Irving G Joshua; William L Dean
Journal:  Clin Exp Hypertens       Date:  2002-07       Impact factor: 1.749

8.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

9.  Cerebrovascular disorders caused by hyperfibrinogenaemia.

Authors:  Nino Muradashvili; Reeta Tyagi; Neetu Tyagi; Suresh C Tyagi; David Lominadze
Journal:  J Physiol       Date:  2016-06-16       Impact factor: 5.182

10.  Proteolytic Cleavage of the Red Blood Cell Glycocalyx in a Genetic Form of Hypertension.

Authors:  Cécile Pot; Angela Y Chen; Jessica N Ha; Geert W Schmid-Schönbein
Journal:  Cell Mol Bioeng       Date:  2011-12-01       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.